Amedeo Smart

Free Medical Literature Service



Ischemic Heart Disease

  Free Subscription

Articles published in
J Cardiovasc Pharmacol
    September 2017
  1. JAZMIN FM, Diana RH, Citali SH, Diego LM, et al
    Sex Differences In Vascular Reactivity To Angiotensin Ii During The Evolution Of Myocardial Infarction.
    J Cardiovasc Pharmacol. 2017 Sep 29. doi: 10.1097/FJC.0000000000000542.
    >> Share

  2. FUSI F, Durante M, Gorelli B, Perrone MG, et al
    MC225, a novel probe for P-glycoprotein PET Imaging at the blood-brain barrier: in vitro cardiovascular safety evaluation.
    J Cardiovasc Pharmacol. 2017 Sep 1. doi: 10.1097/FJC.0000000000000536.
    >> Share

    August 2017
  3. AUDET N, Dabouz R, Allen BG, Hebert TE, et al
    Nucleoligands- repurposing GPCR ligands to modulate nuclear-localized GPCRs in the cardiovascular system.
    J Cardiovasc Pharmacol. 2017 Aug 29. doi: 10.1097/FJC.0000000000000535.
    >> Share

  4. LIU ZY, Hu S, Zhong QW, Tian CN, et al
    N-Methyl-D-Aspartate Receptor (NMDAR)-Driven Calcium Influx Potentiates the Adverse Effects of Myocardial Ischemia-Reperfusion Injury Ex Vivo.
    J Cardiovasc Pharmacol. 2017 Aug 4. doi: 10.1097/FJC.0000000000000527.
    >> Share

    July 2017
  5. KLJUCEVIC N, Milat AM, Grga M, Mudnic I, et al
    White wine consumption influences inflammatory phase of repair following myocardial infarction in rats.
    J Cardiovasc Pharmacol. 2017 Jul 19. doi: 10.1097/FJC.0000000000000519.
    >> Share

  6. CAO S, Zhou Q, Chen JL, Cui JJ, et al
    Comparison of Intracoronary and Intravenous Ultrasound-targeted Microbubble Destruction-mediated Ang1 Gene Transfection on Left Ventricular Remodeling in Canines With Acute Myocardial Infarction.
    J Cardiovasc Pharmacol. 2017;70:25-33.
    >> Share

    April 2017
  7. SERVILLO L, D'Onofrio N, Balestrieri ML
    Ergothioneine Antioxidant Function: From Chemistry to Cardiovascular Therapeutic Potential.
    J Cardiovasc Pharmacol. 2017;69:183-191.
    >> Share

    March 2017
    Non-canonical roles of GRKs in cardiovascular signaling.
    J Cardiovasc Pharmacol. 2017 Mar 17. doi: 10.1097/FJC.0000000000000483.
    >> Share

  9. MAURO AG, Mezzaroma E, Torrado J, Kundur P, et al
    Reduction of Myocardial Ischemia-Reperfusion Injury by Inhibiting Interleukin-1 Alpha.
    J Cardiovasc Pharmacol. 2017;69:156-160.
    >> Share

    February 2017
  10. MAURO AG, Mezzaroma E, Marchetti C, Narayan P, et al
    A Preclinical Translational Study Of The Cardioprotective Effects Of Plasma Derived Alpha-1 Anti-Trypsin In Acute Myocardial Infarction.
    J Cardiovasc Pharmacol. 2017 Feb 13. doi: 10.1097/FJC.0000000000000474.
    >> Share

  11. BORGHI C, Omboni S, Novo S, Vinereanu D, et al
    Early Treatment With Zofenopril And Ramipril In Combination With Acetyl Salicylic Acid In Patients With Left Ventricular Systolic Dysfunction After Acute Myocardial Infarction: Results Of A 5-Year Follow-Up Of Patients Of The Smile-4 Study.
    J Cardiovasc Pharmacol. 2017 Feb 13. doi: 10.1097/FJC.0000000000000473.
    >> Share

    January 2017
  12. SUN J, Xiang Q, Li C, Wang Z, et al
    Efficacy and safety of novel oral P2Y12 receptor inhibitors in ST-segment elevation myocardial infarction patients undergoing PCI: A systematic review and meta-analysis.
    J Cardiovasc Pharmacol. 2017 Jan 3. doi: 10.1097/FJC.0000000000000459.
    >> Share

    December 2016
  13. KAPLAN A, Altara R, Eid A, Booz GW, et al
    Update on the Protective Role of Regulatory T Cells in Myocardial Infarction: A Promising Therapy to Repair the Heart.
    J Cardiovasc Pharmacol. 2016;68:401-413.
    >> Share

    November 2016
  14. ZHANG L, Lu J, Dong W, Tian H, et al
    Meta-Analysis of Comparison of the Newer P2Y12 Inhibitors (Oral Preparation or Intravenous) to Clopidogrel in Patients with Acute Coronary Syndrome.
    J Cardiovasc Pharmacol. 2016.
    >> Share

    October 2016
  15. BORGHI C, Omboni S, Reggiardo G, Bacchelli S, et al
    Efficacy Of Zofenopril Compared To Placebo And Other Ace-Inhibitors In Patients With Acute Myocardial Infarction And Previous Cardiovascular Risk Factors: A Pooled Individual Data Analysis Of Four Randomized, Double-Blind, Controlled, Prospective Stud
    J Cardiovasc Pharmacol. 2016.
    >> Share

  16. SEPARHAM A, Ghaffari S, Najafi H, Ghaffari R, et al
    The Impact of Allopurinol on Patients With Acute ST Elevation Myocardial Infarction Undergoing Thrombolytic Therapy.
    J Cardiovasc Pharmacol. 2016;68:265-268.
    >> Share

    September 2016
  17. WANG C, Li Y, Yang X, Bi S, et al
    Tetramethylpyrazine and astragaloside IV synergistically ameliorate left ventricular remodeling and preserve cardiac function in a rat myocardial infarction model.
    J Cardiovasc Pharmacol. 2016.
    >> Share

    July 2016
  18. MA F, Li T, Zhang H, Wu G, et al
    MiR-30s Family inhibit the Proliferation and Apoptosis in Human Coronary Artery Endothelial Cells through Targeting the 3'UTR Region of ITGA4 and PLCG1.
    J Cardiovasc Pharmacol. 2016.
    >> Share

    June 2016
  19. YANG Q, Wang HC, Liu Y, Gao C, et al
    Resveratrol cardioprotection against myocardial ischemia/reperfusion injury involves upregulation of adiponectin levels and multimerization in type 2 diabetic mice.
    J Cardiovasc Pharmacol. 2016.
    >> Share

    May 2016
  20. CASCON-PEREZ JD, Abellan-Huerta J, Giner-Caro JA, Dau-Villareal DF, et al
    Effectiveness and safety of bivalirudin during percutaneous coronary intervention in acute coronary syndrome in the real world. CARTAGOMAX study.
    J Cardiovasc Pharmacol. 2016.
    >> Share

Free Medical Abstracts
Privacy Policy

© Amedeo 1997-2016